Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

Clinical trial NCT04890392 · UNKNOWN

Trial details

NCT number: NCT04890392
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer Advanced Gastroesophageal Junction Adenocarcinoma

Start date: 2021-01-15
Primary completion: 2022-01-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.